Media

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Business Wire

August 10, 2022

Press Release: Prellis Biologics Announces Collaboration with Sanofi

Business Wire

March 22, 2022

Press Release: Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb

Business Wire

January 13, 2022